Advanced search×
×

Journal of Medicinal Chemistry

Print ISSN
0022-2623
Electronic ISSN
1520-4804
Impact factor
5.207
Publisher
ACS
URL
http://pubs.acs.org/journal/jmcmar
Usage rank
54
Article count
24373
Free count
319
Free percentage
0.0130883
PDFs via platforms
Acs, CSA, Proquest, and Acm

  1. New frontiers in kinases: second generation inhibitors.

    Journal of Medicinal Chemistry 57(6):2167 (2014) PMID 24606189

  2. Discovery of novel bacterial RNA polymerase inhibitors: pharmacophore-based virtual screening and hit optimization.

    Journal of Medicinal Chemistry 56(21):8332 (2013) PMID 24112046

    The bacterial RNA polymerase (RNAP) is a validated target for broad spectrum antibiotics. However, the efficiency of drugs is reduced by resistance. To discover novel RNAP inhibitors, a pharmacophore based on the alignment of described inhibitors was used for virtual screening. In an optimization pr...
  3. Combining in silico and biophysical methods for the development of Pseudomonas aeruginosa quorum sensing inhibitors: an alternative approach...

    Journal of Medicinal Chemistry 56(21):8656 (2013) PMID 24083807

    The present work deals with the optimization of an inhibitor of PqsD, an enzyme essential for Pseudomonas aeruginosa quorum sensing apparatus. Molecular docking studies, supported by biophysical methods (surface plasmon resonance, isothermal titration calorimetry, saturation transfer difference NMR)...
  4. New 7-methylguanine derivatives targeting the influenza polymerase PB2 cap-binding domain.

    Journal of Medicinal Chemistry 56(21):8915 (2013) PMID 24134208

    The heterotrimeric influenza virus polymerase performs replication and transcription of viral RNA in the nucleus of infected cells. Transcription by "cap-snatching" requires that host-cell pre-mRNAs are bound via their 5' cap to the PB2 subunit. Thus, the PB2 cap-binding site is potentially a good t...
  5. Structural studies on dinuclear ruthenium(II) complexes that bind diastereoselectively to an antiparallel folded human telomere sequence.

    Journal of Medicinal Chemistry 56(21):8674 (2013) PMID 24088028 PMCID PMC3835060

    We report DNA binding studies of the dinuclear ruthenium ligand [{Ru(phen)2}2tpphz](4+) in enantiomerically pure forms. As expected from previous studies of related complexes, both isomers bind with similar affinity to B-DNA and have enhanced luminescence. However, when tested against the G-quadrupl...
  6. Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP.

    Journal of Medicinal Chemistry 56(21):8931 (2013) PMID 24102134 PMCID PMC3880643

    We previously discovered potent and selective G9a/GLP inhibitors including the cellular chemical probe UNC0638, which displays an excellent separation of functional potency and cell toxicity. However, this inhibitor is not suitable for animal studies due to its poor pharmacokinetic (PK) properties....
  7. Synthesis and biological evaluation of direct thrombin inhibitors bearing 4-(piperidin-1-yl)pyridine at the P1 position with potent anticoag...

    Journal of Medicinal Chemistry 56(21):8696 (2013) PMID 24102612

    The design and synthesis of a new class of nonpeptide direct thrombin inhibitors, built on the structure of 1-(pyridin-4-yl)piperidine-4-carboxamide, are described. Starting from a strongly basic 1-amidinopiperidine derivative (6) showing poor thrombin (fIIa) and factor Xa (fXa) inhibition activitie...
  8. Design of novel potent inhibitors of human uridine phosphorylase-1: synthesis, inhibition studies, thermodynamics, and in vitro influence on...

    Journal of Medicinal Chemistry 56(21):8892 (2013) PMID 24131420

    We describe synthesis and characterization of a new class of ligands that inhibit hUP type 1 (hUP1). The design of ligands was based on a possible SN1 catalytic mechanism and as mimics of the carbocation in the transition state of hUP1. The kinetic and thermodynamic profiles showed that the ligands...
  9. Factors influencing the specificity of inhibitor binding to the human and malaria parasite dihydroorotate dehydrogenases.

    Journal of Medicinal Chemistry 55(12):5841 (2012) PMID 22621375

    The de novo pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase is an emerging drug target for the treatment of malaria. In this context a key property of Plasmodium falciparum DHODH (PfDHODH) is that it can be selectively inhibited over its human homologue (HsDHODH). However...
  10. Design, synthesis, and pharmacological evaluation of glutamate carboxypeptidase II (GCPII) inhibitors based on thioalkylbenzoic acid scaffol...

    Journal of Medicinal Chemistry 55(12):5922 (2012) PMID 22642259

    A series of thiol-based glutamate carboxypeptidase II (GCPII) inhibitors have been synthesized with either a 3-(mercaptomethyl)benzoic acid or 2-(2-mercaptoethyl)benzoic acid scaffold. Potent inhibitors were identified from each of the two scaffolds with IC(50) values in the single-d...